These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25625585)

  • 1. Estimating skin sensitization potency from a single dose LLNA.
    Roberts DW
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):437-43. PubMed ID: 25625585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
    Roberts DW; Api AM; Aptula AO
    Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
    Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
    Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reduced local lymph node assay: the impact of group size.
    Ryan CA; Chaney JG; Kern PS; Patlewicz GY; Basketter DA; Betts CJ; Dearman RJ; Kimber I; Gerberick GF
    J Appl Toxicol; 2008 May; 28(4):518-23. PubMed ID: 17879259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The local lymph node assay and the assessment of relative potency: status of validation.
    Basketter DA; Gerberick F; Kimber I
    Contact Dermatitis; 2007 Aug; 57(2):70-5. PubMed ID: 17627643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency.
    Nukada Y; Ashikaga T; Miyazawa M; Hirota M; Sakaguchi H; Sasa H; Nishiyama N
    Toxicol In Vitro; 2012 Oct; 26(7):1150-60. PubMed ID: 22796097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive identification of human skin sensitization thresholds.
    Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
    Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an in vitro method to estimate the sensitization induction level of contact allergens.
    Galbiati V; Papale A; Marinovich M; Gibbs S; Roggen E; Corsini E
    Toxicol Lett; 2017 Apr; 271():1-11. PubMed ID: 28189648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accounting for data variability, a key factor in in vivo/in vitro relationships: application to the skin sensitization potency (in vivo LLNA versus in vitro DPRA) example.
    Dimitrov S; Detroyer A; Piroird C; Gomes C; Eilstein J; Pauloin T; Kuseva C; Ivanova H; Popova I; Karakolev Y; Ringeissen S; Mekenyan O
    J Appl Toxicol; 2016 Dec; 36(12):1568-1578. PubMed ID: 27080242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the performance of the reduced local lymph node assay for skin sensitization testing.
    Ezendam J; Muller A; Hakkert BC; van Loveren H
    Regul Toxicol Pharmacol; 2013 Jun; 66(1):66-71. PubMed ID: 23459101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
    Piccotti JR; Kawabata TT
    J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The local lymph node assay: past, present and future.
    Kimber I; Dearman RJ; Basketter DA; Ryan CA; Gerberick GF
    Contact Dermatitis; 2002 Dec; 47(6):315-28. PubMed ID: 12581276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin sensitization testing in potency and risk assessment.
    Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
    Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LLNA variability: An essential ingredient for a comprehensive assessment of non-animal skin sensitization test methods and strategies.
    Hoffmann S
    ALTEX; 2015; 32(4):379-83. PubMed ID: 26168096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in vitro human skin test for assessing sensitization potential.
    Ahmed SS; Wang XN; Fielding M; Kerry A; Dickinson I; Munuswamy R; Kimber I; Dickinson AM
    J Appl Toxicol; 2016 May; 36(5):669-84. PubMed ID: 26251951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.